Exits

Name Description Event Datesort icon Acquired By
<a href="http://www.regi.com/" target="_blank">LS9</a> Leading renewable chemical technology developer. Acquired 2014
<a href="http://www.t2biosystems.com/" target="_blank">T2 Biosystems, Inc.</a> Developing innovative diagnostic products to improve patient health. IPO 2014
<a href="http://www.elevenbio.com/" target="_blank">Eleven Biotherapeutics, Inc.</a> Discovering and developing protein therapeutics to treat diseases of the eye. IPO 2014
Celexion LLC Developed powerful platform technologies. Acquired 2015 <a href="http://www.agenusbio.com/" target="_blank">Agenus</a>
Seres Therapeutics Developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome. IPO 2015